Protective Immune Responses Induced by Vaccination with an Expression Genomic Library ofLeishmania major
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
Genetic immunization is a simple method for eliciting an immune response
1992 • 1,505 citations
DNA VACCINES
1997 • 977 citations
CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.
1998 • 457 citations
Gene vaccination: plasmid DNA is more than just a blueprint
1998 • 359 citations
Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major
1997 • 359 citations
Cutting Edge: CpG Oligodeoxynucleotides Trigger Protective and Curative Th1 Responses in Lethal Murine Leishmaniasis
1998 • 349 citations
Immunology of Leishmaniasis
1993 • 337 citations
Protection against mycoplasma infection using expression-library immunization
1995 • 296 citations
Resistance to Leishmania major Induced by Tolerance to a Single Antigen
1996 • 258 citations
Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.
1988 • 236 citations
Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.
1990 • 188 citations
Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major.
1995 • 171 citations
Human and Murine Immune Responses to a NovelLeishmania majorRecombinant Protein Encoded by Members of a Multicopy Gene Family
1998 • 170 citations
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
1995 • 157 citations
LeIF: A Recombinant Leishmania Protein That Induces an IL-12-Mediated Th1 Cytokine Profile
1998 • 146 citations
A Qualitative Progression in HIV Type 1 Glycoprotein 120-Specific Cytotoxic Cellular and Humoral Immune Responses in Mice Receiving a DNA-Based Glycoprotein 120 Vaccine
1994 • 143 citations
Membrane glycoprotein M-2 protects against Leishmania amazonensis infection
1988 • 133 citations
Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis
1995 • 121 citations
Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response
1995 • 107 citations
Septic Arthritis Following Staphylococcus aureus Infection in Mice Lacking Inducible Nitric Oxide Synthase
1998 • 106 citations
Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes. Involvement of the nitric oxide synthase pathway
1994 • 100 citations
Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters
1997 • 88 citations
Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
1984 • 79 citations
Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins.
1992 • 65 citations
Isolation of DNA and RNA from Leishmania
2003 • 37 citations
ELI's coming: expression library immunization and vaccine antigen discovery
1996 • 15 citations